Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-28T00:25:10.985Z Has data issue: false hasContentIssue false
  • English
  • Français

Changes in the Incidences of Multidrug-Resistant and Extensively Drug-Resistant Organisms Isolated in a Military Medical Center

Published online by Cambridge University Press:  02 January 2015

Edward F. Keen III ,
Clinton K. Murray ,
Brian J. Robinson ,
Duane R. Hospenthal ,
Edgie-Mark A. Co  and
Wade K. Aldous
Edward F. Keen III
Affiliation:
San Antonio Military Medical Center, Brooke Army Medical Center, Fort Sam Houston, Texas
Clinton K. Murray*
Affiliation:
San Antonio Military Medical Center, Brooke Army Medical Center, Fort Sam Houston, Texas Uniformed Services University of the Health Science, Bethesda
Brian J. Robinson
Affiliation:
San Antonio Military Medical Center, Brooke Army Medical Center, Fort Sam Houston, Texas
Duane R. Hospenthal
Affiliation:
San Antonio Military Medical Center, Brooke Army Medical Center, Fort Sam Houston, Texas Uniformed Services University of the Health Science, Bethesda
Edgie-Mark A. Co
Affiliation:
Walter Reed Army Institute of Research, Silver Spring, Maryland
Wade K. Aldous
Affiliation:
San Antonio Military Medical Center, Brooke Army Medical Center, Fort Sam Houston, Texas
*
Infectious Disease Service, San Antonio Military Medical Center, Brooke Army Medical Center, 3851 Roger Brooke Drive, Fort Sam Houston, TX 78234 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Extract

Background.

Multidrug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa have emerged as the causes of nosocomial infections in critically ill patients.

Objective.

To characterize the incidence of these MDR bacteria over time in the military healthcare system, comparing isolates recovered from overseas combat casualties with isolates recovered from local military and civilian patients.

Methods.

Retrospective electronic records review of culture and/or susceptibility testing results of patients admitted to a military level I trauma center in San Antonio, Texas, during the period from January 2001 through December 2008. Multidrug resistance was defined as the first isolated organism resistant to 3 or more classes of antimicrobial agents.

Results.

Over time, the percentage of MDR A. baumannii isolates increased from 4% to 55%, whereas the percentage of MDR P. aeruginosa isolates increased from 2% to 8%. Respiratory tract specimens had a higher percentage of MDR A. baumannii isolates (49%), compared with specimens obtained from blood (30%), wound sites (24%), or urine (19%). No difference in the percentages of MDR P. aeruginosa isolates was observed with regard to source of specimen. The percentage of MDR A. baumannii isolates recovered was higher among patients who had been deployed overseas (52%) than among local patients (20%). When isolates recovered from patients in the burn intensive care unit (53% of MDR A. baumannii isolates) were removed from analysis, the percentage of MDR A. baumannii isolates decreased from 38% to 30% while the percentage of MDR P. aeruginosa isolates remained unaffected.

Conclusion.

The percentage of MDR A. baumannii isolates increased in this facility among combat casualties and among local patients, which indicates nosocomial transmission; however, there was no significant increase in the percentage of MDR P. aeruginosa isolates. Isolated changes in the MDR pathogens within a facility can occur. Possible interventions to limit the spread of these organisms could include implementing aggressive infection control practices, controlling antibiotic use, and using active culture surveillance.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 31 , Issue 7 , July 2010 , pp. 728 - 732
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Boucher, HW, Talbot, GH, Bradley, JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1–12.Google Scholar
2.Chopra, I, Schofield, C, Everett, M, et al. Treatment of health-care-associated infections caused by gram-negative bacteria: a consensus statement. Lancet Infect Dis 2008;8:133–139.Google Scholar
3.Klevens, RM, Edwards, JR, Gaynes, RP; National Nosocomial Infections Surveillance System. The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States. Clin Infect Dis 2008;47:927–930.CrossRefGoogle ScholarPubMed
4.Souli, M, Galani, I, Giamarellou, H. Emergence of extensively drug-resistant and pandrug-resistant gram-negative bacilli in Europe. Euro Surveill 2008;13(47). pii: 19045.Google Scholar
5.Naas, T, Coignard, B, Carbonne, A, et al; French Nosocomial Infection Early Warning Investigation and Surveillance Network. VEB-1 extended-spectrum β-lactamase-producing Acinetobacter baumannii, France. Emerg Infect Dis 2006;12:1214–1222.CrossRefGoogle ScholarPubMed
6.Murray, CK. Epidemiology of infections associated with combat-related injuries in Iraq and Afghanistan. J Trauma 2008;64(3 suppl):S232–S238.Google Scholar
7.Murray, CK, Hinkle, MK, Yun, HC. History of infections associated with combat-related injuries. J Trauma 2008;64(3 suppl):S221–S231.Google Scholar
8.Scott, P, Deye, G, Srinivasan, A, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 2007;44:1577–1584.CrossRefGoogle ScholarPubMed
9.Hawley, JS, Murray, CK, Griffith, ME, et al. Susceptibility of Acinetobacter strains isolated from deployed U.S. military personnel. Antimicrob Agents Chemother 2007;51:376–378.Google Scholar
10.Wortmann, G, Weintrob, A, Barber, M, et al. Genotypic evolution of Acinetobacter baumannii strains in an outbreak associated with war trauma. Infect Control Hosp Epidemiol 2008;29:553–555.CrossRefGoogle Scholar
11.Murray, CK, Yun, HC, Griffith, ME, et al. Recovery of multi-drug resistant bacteria from combat personnel evacuated from Iraq and Afghanistan at a single military treatment facility. Mil Med 2009;174:598–604.Google Scholar
12.The National Healthcare Safety Network (NHSN) Manual: Patient Safety Component. Multidrug-resistant Organism (MDRO) and Clostridium difficile-Associated Disease (CDAC) Module Protocol. Atlanta, GA: Division of Healthcare Quality Promotion, National Center for Preparedness, Detection and Control of Infectious Diseases, Centers for Disease Control and Prevention, 2008:1-29. Centers for Disease Control and Prevention Web site, http://www.cdc.gov/nhsn/mdro_cdad.html. Published May 2010. Accessed May 18, 2010.Google Scholar
13. Simple Interactive Statistical Analysis, http://www.quantitativeskills.com/sisa/index.htm. Accessed August 5, 2009.Google Scholar
14.Clinical and Laboratory Standards Insitute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Information Supplement. CLSI document M100-S19. Wayne, PA: Clinical and Laboratory Standards Institute; 2009.Google Scholar
15.Tan, TY, Ng, LSW. Comparison of three standardized disc susceptibility testing methods for Colistin. J Antimicrob Chemother 2006;58:864–867.CrossRefGoogle ScholarPubMed
16.Albrecht, MC, Griffith, ME, Murray, CK, et al. Impact of Acinetobacter infection on the mortality of burn patients [published correction appears in J Am Coll Surg 2007;204(1): 191]. J Am Coll Surg 2006;203(4): 546–550.Google Scholar
17.Yun, HC, Branstetter, JG, Murray, CK. Osteomyelitis in military personnel wounded in Iraq and Afghanistan. J Trauma 2008;64:S163–S168.Google Scholar
18.Kang, G, Hartzell, JD, Howard, R, et al. Mortality associated with Acinetobacter baumannii complex bacteremia among patients with war-related trauma. Infect Control Hosp Epidemiol 2010;31:92–94.Google Scholar
19.Giske, CG, Monnet, DL, Cars, O, Carmeli, Y; ReAct-Action on Antibiotic Resistance. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 2008;52:813–821.Google Scholar